An Immunoassay to Rapidly Measure Acetaminophen Protein Adducts Accurately Identifies Patients With Acute Liver Injury or Failure
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
BACKGROUND & AIMS A rapid and reliable point‐of‐care assay to detect acetaminophen protein adducts in the serum of patients with acute liver injury could improve diagnosis and management. AcetaSTAT is a competitive immunoassay used to measure acetaminophen protein adducts formed by toxic metabolites in serum samples from patients. We compared the accuracy of AcetaSTAT vs high‐pressure liquid chromatography with electrochemical detection (HPLC‐EC; a sensitive and specific quantitative analytic assay) to detect acetaminophen protein adducts. METHODS We collected serum samples from 19 healthy individuals (no liver injury, no recent acetaminophen use), 29 patients without acetaminophen‐associated acute liver injury, and 33 patients with acetaminophen‐associated acute liver injury participating in the Acute Liver Failure Study Group registry. Each serum sample was analyzed by AcetaSTAT (reported as test band amplitude) and HPLC‐EC (the reference standard). We also collected data on patient age, sex, weight, level of alanine aminotransferase on test day and peak values, concentration of acetaminophen, diagnoses (by site investigator and causality review committee), and outcome after 21 days. Differences between groups were analyzed using the Fisher exact test for categoric variables and the Kruskal–Wallis test or rank‐sum test for continuous variables. RESULTS AcetaSTAT discriminated between patients with and without acetaminophen‐associated acute liver injury; the median AcetaSTAT test band amplitude for patients with acetaminophen‐associated acute liver injury was 584 (range, 222–1027) vs 3678 (range, 394–8289) for those without (P < .001). AcetaSTAT identified patients with acetaminophen‐associated acute liver injury with 100% sensitivity, 86.2% specificity, a positive predictive value of 89.2%, and a negative predictive value of 100%. Results from AcetaSTAT were positive in 4 subjects who received a causality review committee diagnosis of non–acetaminophen‐associated acute liver injury; HPLC‐EC and biochemical profiles were consistent with acetaminophen‐associated acute liver injury in 3 of these cases. CONCLUSIONS The competitive immunoassay AcetaSTAT shows a high degree of concordance with HPLC‐EC results in identifying patients with acetaminophen‐associated acute liver injury. This rapid and simple assay could increase early detection of this disorder and aid clinical management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ostapowicz, G., Fontana, R. J., Schiødt, F. V., Larson, A., Davern, T. J., Han, S. H. B., McCashland, T. M., Shakil, A. O., Hay, J. E., Hynan, L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00007 · Cited by 2,227
Self-citationAcetaminophen Poisoning and Toxicity
Rumack, B. H., & Matthew, H. (1975) · Pediatrics · doi:10.1542/peds.55.6.871 · Cited by 640 · cited 1×
“During the early stages of toxicity, diagnosis is based on a combination of medical history (use of acetaminophencontaining products) and detection of an increased acetaminophen level in the peripheral circulation.(4) However, ALF patients by definition have impaired mental status and/or may not be forthcoming about t…”
Measurement of Serum Acetaminophen–Protein Adducts in Patients With Acute Liver Failure
Davern, T. J., James, L. P., Hinson, J. A., Polson, J., Larson, A. M., Fontana, R. J., Lalani, E., Munoz, S., Shakil, A. O., & Lee, W. M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.033 · Cited by 284
Self-citationHawton, K., Bergen, H., Simkin, S., Dodd, S., Pocock, P., Bernal, W., Gunnell, D., & Kapur, N. (2013) · BMJ · doi:10.1136/bmj.f403 · Cited by 273
James, L. P., Letzig, L., Simpson, P. M., Capparelli, E., Roberts, D. W., Hinson, J. A., Davern, T. J., & Lee, W. M. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.026195 · Cited by 175 · cited 3×
“or greater adduct-derived acetaminophen cysteine corresponded to serious acetaminophen toxicity as definedbyan increase of ALT level greater than 1000 IU/L in patients with known acetaminophen ALF (sensitivity, 97%; specificity, 95%).(12,14)”
Self-citation
Cited by
Stravitz, R. T., & Lee, W. M. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31894-x · Cited by 844
Self-citationRamachandran, A., & Jaeschke, H. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1679919 · Cited by 326
Drug-induced liver injury: Highlights of the recent literature
Real, M., Barnhill, M. S., Higley, C., Rosenberg, J., & Lewis, J. H. (2019) · Drug Safety · doi:10.1007/s40264-018-0743-2 · Cited by 103
Risk prediction of hepatotoxicity in paracetamol poisoning
Wong, A., & Graudins, A. (2017) · Clinical Toxicology · doi:10.1080/15563650.2017.1317349 · Cited by 88
“2% for differentiating patients with paracetamol-induced acute liver injury compared to other causes of acute liver injury in this small study [67].”
BackgroundMethodEarly acetaminophen-protein adducts predict hepatotoxicity following overdose (ATOM-5)
Chiew, A. L., James, L. P., Isbister, G. K., Pickering, J. W., McArdle, K., Chan, B. S. H., & Buckley, N. A. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.030 · Cited by 53
Self-citation
Metadata
- Authors
- Roberts, D. W., Lee, W. M., Hinson, J. A., Bai, S., Swearingen, C. J., Stravitz, R. T., Reuben, A., Letzig, L., Simpson, P. M., Rule, J., Fontana, R. J., Ganger, D., Reddy, K. R., Liou, I., Fix, O., & James, L. P.
- Venue
- Clinical Gastroenterology and Hepatology
- Publisher
- Elsevier BV
- Published
- 2017-04
- Volume
- 15
- Issue
- 4
- Pages
- 555-562.e3
- ISSN
- 1542-3565 (ISSN-L)
- OpenAlex
- W2519450735
- Cited by
- 66
- References
- 5
- FWCI
- 11.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.